The Gamalei institute in Moscow, Russia, completed its phase two testing of the COVID 19 vaccine last week. It’s presently due to get underway with phase three of the testing, which expands the testing into a more extensive number of people. The initial phase was conducted within a small population. During the second phase, the vaccine was tested based on clinical trial episodes. According to the concerned authority of the Institute of Gamalei, the paperwork is going on for registration and legal formalities of the potential vaccine.
The Russian direct investment fund, the sovereign wealth fund that finances every vaccine development of Russia. RDIF CEO Kirill Dmitriev says, “It is a Sputnik moment “Americans were surprised when they heard Sputnik’s beeping. It is the same with this vaccine. Russia will have got there first”. Three different facilities will start producing the vaccine on a large scale. They also said they would start immunizing people from early October 2020.
WHO’s Concerns About Russia’s Vaccine
World health organization expressed their concerns over the rapid and quick vaccine development. They claim that there wouldn’t be necessary steps taken before manufacturing vaccines in large scales. The period for the side effects and the disadvantages won’t be present during the early phase. There are also high chances of neglect throughout the process. Presently Russia is the fourth largest country with the maximum number of COVID 19 positive cases. WHO frequently questions the safety and the effectiveness of the product from the beginning. During phase one testing, the number of people tested was 38, and during phase two, the number of people tested is only one hundred. Considering the number of tests conducting around the world, they are broader and more substantial, along with the time they took, are satisfactory. There are also allegations about the inoculation with Russia’s potential vaccine with the elites that are still unproven in the country.
For testing the vaccine, Russia already came into contact with its primary partners, including South Africa, India, and Saudi Arabia. Presently three of these countries are in the reservation for the purchase of the Russi’s potential vaccine against COVID 19. If the vaccine is proven effective and safe, the countries in the reservation will start importing it by the beginning of 2021.
They also claim that the diplomatic officials from America, Canada, and Britain tried to hack their data regarding the manufacturing of the COVID 19 vaccine.